1. Home
  2. Health
  3. Colon Cancer

Radiation Therapy for Prostate Cancer Increases Rectal Cancer Risk

by Donna Myers
for About.com

Updated: August 26, 2006

About.com Health's Disease and Condition content is reviewed by the Medical Review Board


According to a study published in Gastroenterology, any man who has received radiation therapy for prostate cancer should be aggressively monitored for rectal cancer.

Researchers studied approximately 85,000 men with prostate cancer. About 30,000 had received radiation therapy; the remaining 55,000 had been treated with surgery alone.

When the prostate is treated with radiation, at least part of the rectum receives radiation, too. Apparently, this causes a predisposition to cancer. The study found that men who'd received radiation therapy were 70% more likely to develop rectal cancer than men who hadn't.

What does this mean for you? According to the study's lead author, anyone who received radiation therapy for prostate cancer should be aggressively monitored for rectal cancer starting five years after treatment. If that describes you, you may want to give your doctor a call.

Sources:
  1. Barclay, Laurie. Radiation Therapy for Prostate Cancer May Increase Rectal Cancer Risk in Irradiated Field. Medscape Medical News. 4 Apr. 2006. 26 Aug. 2006 [http://www.medscape.com/viewarticle/502437].
  2. Radiation Therapy for Prostate Cancer Nearly Doubles the Risk of Rectal Cancer. American Gastroenterological Association. 1 Apr. 2005. 26 Aug. 2006 [http://www.gastro.org/wmspage.cfm?parm1=1810].

Explore Colon Cancer
About.com Special Features

Learn how you can reduce your your numbers with these nutrition and exercise tips. More >

Keep yourself, and your family, happy and healthy this fall with these tips. More >

We comply with the HONcode standard for trustworthy health information: verify here.
  1. Home
  2. Health
  3. Colon Cancer
  4. Research
  5. Risk Factors
  6. Radiation Therapy for Prostate Cancer Increases Rectal Cancer Risk

©2009 About.com, a part of The New York Times Company.

All rights reserved.